BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12378339)

  • 1. Surgery for gastric cancer increases plasma levels of vascular endothelial growth factor and von Willebrand factor.
    Ikeda M; Furukawa H; Imamura H; Shimizu J; Ishida H; Masutani S; Tatsuta M; Kawasaki T; Satomi T
    Gastric Cancer; 2002; 5(3):137-41. PubMed ID: 12378339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    McGirt MJ; Lynch JR; Blessing R; Warner DS; Friedman AH; Laskowitz DT
    Neurosurgery; 2002 Nov; 51(5):1128-34; discussion 1134-5. PubMed ID: 12383357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery.
    Karayiannakis AJ; Syrigos KN; Polychronidis A; Zbar A; Kouraklis G; Simopoulos C; Karatzas G
    Ann Surg; 2002 Jul; 236(1):37-42. PubMed ID: 12131083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ; Li JR; Li ZB
    Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
    Lin SY; Wang YY; Sheu WH
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):513-8. PubMed ID: 12641636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Yanoma S; Noguchi Y
    Cancer Lett; 2000 May; 153(1-2):7-12. PubMed ID: 10779624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor.
    Kim HK; Song KS; Park YS; Kang YH; Lee YJ; Lee KR; Kim HK; Ryu KW; Bae JM; Kim S
    Eur J Cancer; 2003 Jan; 39(2):184-91. PubMed ID: 12509950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
    Komorowski J; Pasieka Z; Jankiewicz-Wika J; Stepień H
    Thyroid; 2002 Aug; 12(8):655-62. PubMed ID: 12225633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia.
    Brunner B; Gunsilius E; Schumacher P; Zwierzina H; Gastl G; Stauder R
    J Hematother Stem Cell Res; 2002 Feb; 11(1):119-25. PubMed ID: 11847008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
    Braybrooke JP; O'Byrne KJ; Propper DJ; Blann A; Saunders M; Dobbs N; Han C; Woodhull J; Mitchell K; Crew J; Smith K; Stephens R; Ganesan TS; Talbot DC; Harris AL
    Clin Cancer Res; 2000 Dec; 6(12):4697-704. PubMed ID: 11156222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.
    Felmeden DC; Spencer CG; Belgore FM; Blann AD; Beevers DG; Lip GY
    Am J Hypertens; 2003 Jan; 16(1):11-20. PubMed ID: 12517677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
    Minagawa N; Nakayama Y; Hirata K; Onitsuka K; Inoue Y; Nagata N; Itoh H
    Anticancer Res; 2002; 22(5):2957-63. PubMed ID: 12530025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity.
    Yang X; Sun HJ; Li ZR; Zhang H; Yang WJ; Ni B; Wu YZ
    BMC Cancer; 2015 Feb; 15():80. PubMed ID: 25886574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
    Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY
    Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma.
    Huang SP; Wu MS; Wang HP; Yang CS; Kuo ML; Lin JT
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1165-9. PubMed ID: 12453275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer.
    Hyodo I; Doi T; Endo H; Hosokawa Y; Nishikawa Y; Tanimizu M; Jinno K; Kotani Y
    Eur J Cancer; 1998 Dec; 34(13):2041-5. PubMed ID: 10070308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma.
    Lip PL; Felmeden DC; Blann AD; Matheou N; Thakur S; Cunliffe IA; Lip GY
    Br J Ophthalmol; 2002 Nov; 86(11):1299-302. PubMed ID: 12386093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.